HLL Lifecare

HLL Lifecare Limited
Public
Industry Health Care
Founded 1966, Thiruvananthapuram
Headquarters Thiruvananthapuram, Kerala, India
Key people
 Dr. M. Ayyappan,
Chairman & Managing Director
Products Condoms
Hormonal contraception
Surgical Equipment
Revenue IncreaseINR 1059 crores
(FY 2014-2015 provisional)
INR 42 crores provisional
Slogan "Innovating for Healthy Generations"
Website www.lifecarehll.com

HLL Lifecare Limited (formerly Hindustan Latex Limited) (HLL) is an Indian healthcare products manufacturing company based in Thiruvananthapuram, Kerala, India. A Government of India -owned corporation (Public-sector undertaking).

Products

It produces health care products, including: condoms, surgical sutures, hydrocephalus shunts, tissue expanders, blood bags, and contraceptive pills. One of HLL's contraceptive products is ormeloxifene, branded as Saheli, the world’s first and only oral non-hormonal, non-steroidal oral contraceptive, taken as a weekly pill.[1] In 2012, HLL announced a polymerase chain reaction based duplex test kit for chikungunya and dengue fever tests in collaboration with the Rajiv Gandhi Centre for Biotechnology, Trivandrum.[2]

History

Earlier Hindustan Lever Limited, had the acronym HLL, but Hindustan Lever Limited changed their name to Hindustan Unilever Limited with acronym as HUL.

In 2005, HLL established LifeSpring Hospitals, a 50-50 joint venture with the Acumen Fund, a U.S.-based nonprofit global venture philanthropy fund, to provide low-cost maternity services, starting at Hyderabad. Today it has nine hospitals across Andhra Pradesh state.[3][4][5][6]

In February 2014, HLL acquired 74% Equity in Goa Antibiotics and Pharmaceuticals Ltd.[7]

See also

References

  1. ↑ Hindustan Latex is world's largest condom producer Financial Express, Nov 24, 2007.
  2. ↑ "HLL Lifecare to launch chikungunya, dengue diagonstic kits". The Times Of India. 2012-08-08.
  3. ↑ "LifeSpring Hospitals". Acumen Fund website.
  4. ↑ "Current Investors". LifeSpring website.
  5. ↑ "How services firms in India are using disruptive innovation". Mint (newspaper). Feb 3, 2011.
  6. ↑ "HLL Case Study" (PDF). siteresources.worldbank.
  7. ↑ "HLL Lifecare acquires 74% Stake in Goa Antibiotics Ltd". IANS. news.biharprabha.com. Retrieved 25 February 2014.

External links


This article is issued from Wikipedia - version of the Sunday, December 27, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.